Porzio Life Sciences provides Aggregate Spend Regulatory Compliance software solutions for Pharmaceutical, Medical Device & Biotech companies comply with Affordable Care Act and Sunshine Act.
HomeProducts & ServicesMedia LibraryAbout UsContact UsSubscriber LoginGoToMeetingBlog

About Us



Porzio Pharmaceutical Services, LLC
 
About Us > Recent Articles

Recent Articles


September 24, 2014   Shoot First… Michigan Imposes New Requirements On The Pharmaceutical Supply Chain
Porzio Life Sciences, LLC
by Frank Fazio
     
September 5, 2014   Massachusetts Life Science Companies: Stuck Between A Rock And A Hard Place
Porzio Life Sciences, LLC
by Frank Fazio
     
08/2014   Do Start Believin': The Life Sciences Industry's Journey to Global Transparency
Porzio Life Sciences, LLC
by D. Jeffrey Campbell and Brian P. Sharkey
     
04/01/2014   Industrial Site Recovery Act: An Environmental Consideration For New Jersey Life Sciences Facilities
Porzio, Bromberg & Newman P.C.
by Lisa M. Bromberg and Thomas Spiesman
     
02/27/2014   FDA’s Office of Prescription Drug Promotion (OPDP) Enforcement: A Summary of 2013 Warning and Untitled Letters
Porzio Life Sciences, LLC
by Jennifer A. Romanski, J.D. and Kim C. Capone
     
12/23/2013   Getting the Deal Through: Life Sciences 2014 - United States Chapter
Life Sciences in 24 Jurisdictions Worldwide
by John Patrick Oroho and Brian P. Sharkey
     
10/23/2013  
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
08/19/2013   Say Hi To Oscar: The New Kid That May Change Health Insurance
F
orbes.com
by Scott S. Liebman
     
08/01/2013   The Ongoing Global Transformation in Life Sciences Transparency
Porzio Life Sciences, LLC
by D. Jeffrey Campbell and Brian P. Sharkey
     
07/24/2013  
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/25/2013   Here Comes The Sunshine Act — This Time, In Europe
Law360
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/10/2013   An IMDA Article on Frank Fazio’s “Are you Licensed to Sell?” Presentation
IMDA Article
by Frank Fazio 
     
09/28/2012   Licensed to Sell? Frank Fazio Quoted In Article on Medical Device Licensing Required by States
IMDA Update
by Frank Fazio 
     
08/14/2012   The Trend Towards Global Transparency: A Challenging New World for the Life Sciences Industry
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey
     
06/22/2012   Pharmaceutical Sales Representatives Exempt From Overtime
Porzio Compliance Alert
by Kerri A. Wright
     
03/19/2012   Understanding the Sunshine Act: Dispersing the Clouds of Confusion
Porzio, Bromberg & Newman P.C.
by Christine N. Bradshaw and Sandra González
     
03/15/2013  
Bloomberg BNA Pharmaceutical Law & Industry Report
by D. Jeffrey Campbell and Brian P. Sharkey
     
02/29/2012   Getting the Deal Through: Life Sciences 2012 - United States Chapter
Life Sciences in 25 Jurisdictions Worldwide
by John Patrick Oroho, Kenneth R. Meyer, and Brian P. Sharkey
     
02/13/2012   Are Pharma Sales Reps Entitled to Overtime Pay?
New Jersey Law Journal
by Kerri A. Wright
     
12/19/2011   CMS Publishes Draft Regulations to Implement the Sunshine Act
Porzio Compliance Alert
by Christine N. Bradshaw
     
05/01/2010   Taking Stock of the Marketing Retrictions and Prohibitions of Academic Medical Centers
FDLI Update
by D. Jeffrey Campbell and Christine N. Bradshaw
     
04/01/2010   Thriving Through Turmoil: Managing Sales and Marketing Regulation of the Medical Device Industry
FDLI Update
by D. Jeffrey Campbell and Jennifer A. Sanfilippo
     
02/01/2010   The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives
FDLI Update
by D. Jeffrey Campbell and Sarina D. Rivera
     
09/01/2009   Navigating Loss Reporting: How to Meet FDA and State Reporting Requirements
Thought Leadership Sales and Marketing Compliance
by Anne E. Wagstaff, John E. Niznik and Rhonda Sobral O'Toole
     
09/01/2009   What's All the Commotion Over Aggregate Spend?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Christine N. Bradshaw
     
06/01/2009   Court Prescribes No Overtime for Pharmaceutical Sales Rep
New Jersey Defense Quarterly
by Kerri A. Wright
     
05/28/2009   Sales Rep Nightmares: Emerging Issues in Marketing Compliance
FDLI Update
by John Patrick Oroho and Christine N. Bradshaw
     
03/09/2009   Over-the-Counter and Prescription Drug Manufacturers are Granted a One Year Reprieve from the Burdensome Requirements of the Consumer Product Safety Improvement Act
Porzio Pharmaceutical Alert
by Frank Fazio and Anne E. Wagstaff
     
02/01/2009   The End or Just the Beginning? Exploring Federal Preemption of State and Distribution Laws
Pharmaceutical Commerce
by Sarina D. Rivera, Jennifer A. Sanfilippo and Kiaema R. Reid
     
09/11/2009   DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Jennifer A. Romanski and Sarina D. Rivera
     
08/27/2008   Navigating Through the Disparities of State Marketing Tracking and Disclosure Laws
Thought Leadership Sales and Marketing Compliance
by Garineh S. Dovletian and Christopher R. Corallo
     
06/18/2007   Newly Enacted Nevada Statute Requires Adoption of a "Marketing Code of Conduct."
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Christopher R. Corallo and John Patrick Oroho
     
06/01/2007   State Marketing Disclosure Laws - The Unintended Consequences
FDLI Update
by Sarina D. Rivera
     
05/30/2007   Online DTC: Marketing Push Meets Consumer Pull
Pharmaceutical Commerce
by John Patrick Oroho
     
05/21/2007   Can Prosecutors Use Data from Sample Distribution as Evidence of Off-Label Promotion?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Scott S. Liebman


 
  << Back